140 related articles for article (PubMed ID: 11359772)
1. Disabled-2 exerts its tumor suppressor activity by uncoupling c-Fos expression and MAP kinase activation.
He J; Smith ER; Xu XX
J Biol Chem; 2001 Jul; 276(29):26814-8. PubMed ID: 11359772
[TBL] [Abstract][Full Text] [Related]
2. Disabled-2 mediates c-Fos suppression and the cell growth regulatory activity of retinoic acid in embryonic carcinoma cells.
Smith ER; Capo-chichi CD; He J; Smedberg JL; Yang DH; Prowse AH; Godwin AK; Hamilton TC; Xu XX
J Biol Chem; 2001 Dec; 276(50):47303-10. PubMed ID: 11577091
[TBL] [Abstract][Full Text] [Related]
3. Disassociation of MAPK activation and c-Fos expression in F9 embryonic carcinoma cells following retinoic acid-induced endoderm differentiation.
Smith ER; Smedberg JL; Rula ME; Hamilton TC; Xu XX
J Biol Chem; 2001 Aug; 276(34):32094-100. PubMed ID: 11402055
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory role of DOC-2/DAB2 in growth factor receptor-mediated signal cascade. DOC-2/DAB2-mediated inhibition of ERK phosphorylation via binding to Grb2.
Zhou J; Hsieh JT
J Biol Chem; 2001 Jul; 276(30):27793-8. PubMed ID: 11371563
[TBL] [Abstract][Full Text] [Related]
6. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a novel negative regulator (DOC-2/DAB2) of c-Src in normal prostatic epithelium and cancer.
Zhou J; Scholes J; Hsieh JT
J Biol Chem; 2003 Feb; 278(9):6936-41. PubMed ID: 12473651
[TBL] [Abstract][Full Text] [Related]
8. Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells.
Sheng Z; Sun W; Smith E; Cohen C; Sheng Z; Xu XX
Oncogene; 2000 Oct; 19(42):4847-54. PubMed ID: 11039902
[TBL] [Abstract][Full Text] [Related]
9. Cyclic AMP and mitogen-activated protein kinases are required for glutamate-dependent cyclic AMP response element binding protein and Elk-1 phosphorylation in the dorsal striatum in vivo.
Choe ES; McGinty JF
J Neurochem; 2001 Jan; 76(2):401-12. PubMed ID: 11208903
[TBL] [Abstract][Full Text] [Related]
10. Activation of ternary complex factor Elk-1 by stress-activated protein kinases.
Gille H; Strahl T; Shaw PE
Curr Biol; 1995 Oct; 5(10):1191-200. PubMed ID: 8548291
[TBL] [Abstract][Full Text] [Related]
11. PTEN blocks insulin-mediated ETS-2 phosphorylation through MAP kinase, independently of the phosphoinositide 3-kinase pathway.
Weng LP; Brown JL; Baker KM; Ostrowski MC; Eng C
Hum Mol Genet; 2002 Jul; 11(15):1687-96. PubMed ID: 12095911
[TBL] [Abstract][Full Text] [Related]
12. Lack of Elk-1 phosphorylation and dysregulation of the extracellular regulated kinase signaling pathway in senescent human fibroblast.
Tresini M; Lorenzini A; Frisoni L; Allen RG; Cristofalo VJ
Exp Cell Res; 2001 Oct; 269(2):287-300. PubMed ID: 11570821
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
Wu W; Pew T; Zou M; Pang D; Conzen SD
J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways.
Gu J; Tamura M; Yamada KM
J Cell Biol; 1998 Nov; 143(5):1375-83. PubMed ID: 9832564
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun.
Meyer-ter-Vehn T; Covacci A; Kist M; Pahl HL
J Biol Chem; 2000 May; 275(21):16064-72. PubMed ID: 10747974
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin stimulates the ERK-->Elk-1-->Fos/AP-1 pathway in mesangial cells.
El-Dahr SS; Dipp S; Baricos WH
Am J Physiol; 1998 Sep; 275(3):F343-52. PubMed ID: 9729506
[TBL] [Abstract][Full Text] [Related]
17. Disabled-2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cells.
Tseng CP; Huang CL; Huang CH; Cheng JC; Stern A; Tseng CH; Chiu DT
FEBS Lett; 2003 Apr; 541(1-3):21-7. PubMed ID: 12706813
[TBL] [Abstract][Full Text] [Related]
18. Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation.
Song RX; McPherson RA; Adam L; Bao Y; Shupnik M; Kumar R; Santen RJ
Mol Endocrinol; 2002 Jan; 16(1):116-27. PubMed ID: 11773443
[TBL] [Abstract][Full Text] [Related]
19. Estrogen regulation of c-fos gene expression through phosphatidylinositol-3-kinase-dependent activation of serum response factor in MCF-7 breast cancer cells.
Duan R; Xie W; Li X; McDougal A; Safe S
Biochem Biophys Res Commun; 2002 Jun; 294(2):384-94. PubMed ID: 12051724
[TBL] [Abstract][Full Text] [Related]
20. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
Wen-Sheng W
Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
